Chagas Cardiomyopathy — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Chronic Chagas disease (Trypanosoma cruzi cardiomyopathy)
RBBB plus left anterior hemiblock with dilated cardiomyopathy and apical aneurysm in a patient from Bolivia (highly endemic for Chagas disease) with a history of childhood chagoma (entry site lesion from triatomine bug bite) is classic chronic Chagas cardiomyopathy. T. cruzi causes progressive myocardial damage over decades. Diagnosis is confirmed by T. cruzi serology (two different serological tests). Treatment in the chronic phase with Benznidazole may slow progression (BENEFIT trial showed parasitological but not clinical benefit). Heart failure management follows standard guidelines. Screening of family members is recommended.
Reference: WHO 2024 – Chagas disease; NICE CKS 2024 – Chagas; BENEFIT Trial 2015